ENST00000359162.6:c.-13-80180G>C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000359162.6(ESRRG):c.-13-80180G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.745 in 151,930 control chromosomes in the GnomAD database, including 43,147 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.74 ( 43147 hom., cov: 31)
Consequence
ESRRG
ENST00000359162.6 intron
ENST00000359162.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 2.89
Publications
3 publications found
Genes affected
ESRRG (HGNC:3474): (estrogen related receptor gamma) This gene encodes a member of the estrogen receptor-related receptor (ESRR) family, which belongs to the nuclear hormone receptor superfamily. All members of the ESRR family share an almost identical DNA binding domain, which is composed of two C4-type zinc finger motifs. The ESRR members are orphan nuclear receptors; they bind to the estrogen response element and steroidogenic factor 1 response element, and activate genes controlled by both response elements in the absence of any ligands. The ESRR family is closely related to the estrogen receptor (ER) family. They share target genes, co-regulators and promoters, and by targeting the same set of genes, the ESRRs seem to interfere with the ER-mediated estrogen response in various ways. It has been reported that the family member encoded by this gene functions as a transcriptional activator of DNA cytosine-5-methyltransferases 1 (Dnmt1) expression by direct binding to its response elements in the DNMT1 promoters, modulates cell proliferation and estrogen signaling in breast cancer, and negatively regulates bone morphogenetic protein 2-induced osteoblast differentiation and bone formation. Multiple alternatively spliced transcript variants have been identified, which mainly differ at the 5' end and some of which encode protein isoforms differing in the N-terminal region. [provided by RefSeq, Aug 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.884 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LOC124904512 | XR_007066880.1 | n.2609G>C | non_coding_transcript_exon_variant | Exon 1 of 2 | ||||
| ESRRG | NM_001134285.3 | c.-13-80180G>C | intron_variant | Intron 3 of 8 | NP_001127757.1 | |||
| ESRRG | NM_001243509.2 | c.-13-80180G>C | intron_variant | Intron 3 of 8 | NP_001230438.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ESRRG | ENST00000359162.6 | c.-13-80180G>C | intron_variant | Intron 2 of 7 | 1 | ENSP00000352077.2 | ||||
| ESRRG | ENST00000360012.7 | c.-14+47272G>C | intron_variant | Intron 1 of 6 | 1 | ENSP00000353108.3 | ||||
| ESRRG | ENST00000361395.6 | c.-13-80180G>C | intron_variant | Intron 2 of 7 | 1 | ENSP00000354584.2 |
Frequencies
GnomAD3 genomes AF: 0.745 AC: 113081AN: 151812Hom.: 43095 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
113081
AN:
151812
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.745 AC: 113183AN: 151930Hom.: 43147 Cov.: 31 AF XY: 0.743 AC XY: 55175AN XY: 74226 show subpopulations
GnomAD4 genome
AF:
AC:
113183
AN:
151930
Hom.:
Cov.:
31
AF XY:
AC XY:
55175
AN XY:
74226
show subpopulations
African (AFR)
AF:
AC:
37016
AN:
41494
American (AMR)
AF:
AC:
9941
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
AC:
2582
AN:
3468
East Asian (EAS)
AF:
AC:
2360
AN:
5118
South Asian (SAS)
AF:
AC:
4110
AN:
4814
European-Finnish (FIN)
AF:
AC:
7157
AN:
10570
Middle Eastern (MID)
AF:
AC:
251
AN:
294
European-Non Finnish (NFE)
AF:
AC:
47518
AN:
67914
Other (OTH)
AF:
AC:
1578
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1421
2842
4263
5684
7105
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
838
1676
2514
3352
4190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2433
AN:
3474
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.